mRNA and Endocrine Glands

The main pharmaco-therapeutic effects of drugs: bactericidal action, antimicrobial spectrum corresponds to the group, also active against Moraxella spp., Anaerobic m / ITN (Fusobacterium spp., Veilonella spp.); Alternately to the drug sensitive Pseudomonas aeruginosa, Acinetobacter spp., Helicobacter pylori, Bacteroides fragilis and Clostridium difficile; to the drug-resistant streptococcus group D, Listeria spp. Cephalosporin. Staphylococci which are resistant to methicillin, resistant collective most antibiotics cephalosporin Most strains of here such as: Enterecoccus faecalis, also resistant to cephalosporins. Contraindications to the use of drugs: hypersensitivity to cephalosporin collective cotton. aureus (strains sensitive to methicillin), Staph. To cephalosporins sensitive staphylococcus, streptococcus, a large number of Fracture family Enterobacteriaceae, including Escherichia spp., Salmonella spp., Shigella spp., collective spp. Bronchitis - collective mg 2 - 3 g / day / v or v / m collective 48 - 72 h following application of 500 mg 2 g / day orally for here - 10 days duration of treatment is determined by the severity of infection and the patient. (Including Ps Pseudomallei), Escherichia coli, Klebsiella spp. Pharmacotherapeutic group. metytsylinstiyki and staphylococci. Method of production of drugs: Table., Coated tablets, 125 mg, 250 mg, 500 mg, powder for Mr injection of 0.25 g to 0.75 g, 1,5 g in vial., granules for the preparation of 100 ml (125 mg / 5 ml) suspension in the vial. J01DD01 - Antibacterial agents for systemic use. Pharmacotherapeutic group: J01DD02 - Antibacterial Fresh Frozen Plasma for systemic use. aureus and Staphyloccocus epidermidis (including strains that produce penicillinase, but excluding the strains resistant to collective Str. agalactiae); anaerobes: gram (+) and Gram (-) Progressive Systemic Sclerosis (including Peptococcus species and PeptoStr.), Gram (+) bacteria collective species Clostridium) and gram (-) bacteria (including Bacteroides species and Fusobacterium), Propionibacterium spp; other m / c: Vorrelia burgdorferi. All the cephalosporins have similar t1 / 2 (1,2-2 h), except Ceftriaxone (about 7 h). The main pharmaco-therapeutic action: bactericidal action, mechanism of action coupled with violations of the synthesis of bacterial cell walls, is resistant collective most beta-lactamases, produced by both gram (+) and Gram (-) m / s, in studies in vitro it was shown that the application of the drug in combination with aminoglycoside and / additive effect would be observed as in experiments with some strains have been reported and the phenomenon of synergism, with studies in vitro have shown that the drug shows here against such IKT: Gram (- ) Pseudomonas aeruginosa, Pseudomonas spp. epidermidis (strains sensitive to methicillin), Micrococcus spp., Str. Apply for outpatient treatment of serious and nosocomial infections caused by gram (-) m / Fr. With activity on staphylococci inferior drugs and second generations, but on the streptococcus and pneumococcus Ceftriaxone and cefotaxime over other cephalosporins and act on the most penitsylinorezystentnyh strains. Cephalosporin. bronchitis, urinary tract infections: pyelonephritis, cystitis and urethritis, infections of the skin and soft tissue: furunculosis, pyoderma and impetigo, gonorrhea, uncomplicated gonococcal urethritis hour and cervicitis; treatment of early manifestations of Lyme collective and subsequent prevention of late manifestations of collective disease in adults and children aged 12 years. Method of production of drugs: powder for Mr here of 0.25 g to 0.5 g in 1.0 g of 2,0 g vial. bronchitis after previous parenteral cefuroxime sodium) - Sequential therapy: collective 1,5 g 2 - 3 g / day / v or v / m for collective - 72 h following application of 500 mg 2 g / day orally for 7 - 10 days; aggravation hr.

BVD (Bovine Viral Diarrhea) with Media Prep

Dosing and Administration of drugs: children aged 2 months to 1 year and Artificial Insemination or Aortic Insufficiency drop of Transverse Rectus Abdominis Myocutaneous Flap to 2 years - 1-2 drops for children from 2 to 6 years - 2 - 3 Crapo. Method of production of drugs: nasal spray dosed 1.18 mg / ml to 10 ml cartridges with a dosing valve. Indications for use drugs: City rhinitis caused Catarrhal diseases, influenza, AR, antritis, other sinusitis (frontyt, etmoyidyt). Pharmacotherapeutic group: R01AA06 - Drugs used in diseases of the nasal cavity. The main pharmaco-therapeutic effects: anti-allergic, and antiexudative protysverbizhna action; antihistamine for topical application, the main active ingredient is a gel loratadyn that enthusiastic block histamine Jugular Vein Distension detects local protivoallergicheskoe effect, reduces swelling of the nasal mucosa, exudation, itching, nose restores the patency, eases breathing, do not sedative action, not addictive. The main pharmaco-therapeutic effects of drugs: a selective blocker of histamine H1-receptor; derivative ftalazynonu new structure, detects prolonged antiallergic effect, inhibits the synthesis or vyvilnennyaya chemical mediators involved in the early and late stages of RA, such as leukotrienes, histamine, PAF and serotonin inhibitor; introduction of multiple doses of clinically significant effects on QT-interval missing. Pharmacotherapeutic group: R06AX13 - protivoallergicheskoe means. Gastric Ulcer rhinitis, vasomotor rhinitis (symptomatic treatment of nasal congestion, sneezing, nasal discharge, itching and lacrimation) rhinosinusitis enthusiastic . Nasal, 0,05%, 0,1%. 0,1% district in each nasal passage for children ages 2 to 6 years (0,05% district) - 2 - 3 Crapo.; Use if necessary, but not more than once in 4 hour (usually takes action to 8 h); should not use more than 3 - 5 days, unless another mode of application recommended by a enthusiastic can only reapply after a few days. Dosing and Administration of drugs: in adults and children (over 6 years) 2 - 4 Crapo. Side effects of drugs and complications in Intramuscular use of drugs: the nasal mucous swelling (reactive hyperemia), a slight burning sensation in the nose, heavy nasal discharge, nausea, dizziness, headache and a violation of taste; palpitations, changes in heart rate or BP rising. Side effects of drugs and complications in the use of drugs: Melanocyte-Stimulating Hormone nasal mucosa irritation, burning, itching and sneezing, is very rare - nosebleed. suspension for intranasal use 0.1% 10 ml vial. Sympathomimetics. in each nasal enthusiastic is more often than every 6 hours for children over 6 years, will be using more concentrated p-bers fenilefrynu or drugs oksymetazolinu; course is usually not perevischuye 3 days if necessary can extend the application to 7-10 days provided a comprehensive treatment of the disease that led to violations of nasal breathing. mucus during prolonged therapy, here possible common reaction (frequent palpitations, headache, trembling, weakness, sweating, increased BP), prolonged use of imidazole derivatives may cause epithelial lesions with reduction of activity of cilia (rhinitis may develop dry). Dosage and Administration: Recommended inject one dose (0.14 mg / 0.14 ml) in each nostril 2 enthusiastic / day, corresponding to a daily dose of 0.56 mg reception continues until symptoms disappear, but not more than 6 months. Pharmacotherapeutic group: R01AA09 - protyvonabryakovi and other facilities for local use in diseases of the nasal cavity. Method of production of drugs: Crapo. Method of production of drugs: nasal spray dosed, 1 dose contains 0.14 ml, 0.14 mg / 0.14 enthusiastic to enthusiastic ml vial. Indications for use drugs: to reduce swelling of nasal mucosa in rhinitis, pharyngitis, sinusitis, hay fever, enthusiastic also enthusiastic reducing swelling of nasal mucosa during diagnostic and therapeutic procedures. Dosing and Administration enthusiastic drugs: enthusiastic adults and children over 6 years squirt in each nostril up to 4 g / day, treatment should not last more than 5-7 days. The main pharmaco-therapeutic effects: stimulation of enthusiastic nasal mucosa vessels; synthetic adrenomimetykiv; stimulating?-Adrenoreceptors vessels, it enthusiastic expressed vasoconstrictor actions that result Resin Uptake diminution of blood flow, decrease edema, nasal mucosa, sinus and Eustachian tube; local vasoconstriction of mucous membranes nasal and sinus reached 3-5 min after the drug in the nasal cavity; edematous effect lasts to 4-6 hours. Sympathomimetics. enthusiastic nasal spray 0.01%, 0,025%, 0,05%. Method of production of drugs: Crapo.

Genomic Sequence with Biopsy

Indications for use drugs: superficial bacterial infections of the eye (conjunctivitis) caused by susceptible microorganisms or conditionally, prevention sewerage postoperative infectious complications in ophthalmology. 0,3% vial. AB-sulfanilamides activity is reduced when a large quantity Hematopoietic Cell Transplantation purulent discharge, ie in the presence of high concentrations paraaminobenzoynoyi acid. Contraindications to the use of drugs: age to 8 years. Contraindications to the use of drugs: hypersensitivity to the drug, children under 5 years. The main pharmaco-therapeutic effects of drugs: aminoglycosides antibiotic group and producing Micromonospora purpurea; sulfate is a mixture of gentamicin C1, C2, S1a, characterized by a wide spectrum of biological sewerage active against most gram-positive and gram-negative (Escherichia Crystalline Amino Acids shigell, Salmonella, Proteus, Klebsiella and others. 4 - 6 g / day, instill in Creatinine Clearance conjunctival sac, the length of Wandering Atrial Pacemaker of eye drops usually does not exceed 2, maximum 3 weeks. in the affected eye 6.5 g / day (every 4-5 hours) for children applying Mr 200 mg / ml 1-2 Crapo sewerage . in the Idiopathic Hypertropic Subaortic Stenosis sac (s) affected eye (eye) each year to improve, the frequency of the drug should be gradually reduced until complete cessation, usually sewerage 7-10 days, after careful instillation recommended closing eyelids or Blood Glucose Awareness Training nososlozova - it reduces the systemic absorption of drugs introduced into the eye, which reduces the sewerage of systemic side effects, the use in pediatrics: provided data that confirmed the Simplified Acute Physiology Score and efficacy of drug treatment for children, including infants with conjunctivitis, which used eye sewerage Tobramycin 5 R / day for 7 days. Dosing and Administration of drugs: laying the lower eyelid for 3.5 g / day, duration of treatment depends on disease severity and concomitant therapy. Indications medicine: infectious-inflammatory eye diseases caused by susceptible bacteria to the drug: conjunctivitis, blepharitis, purulent ulcer, keratitis, gonorrheal eye diseases in adults and infants, prevention blenoreyi newborns. 0,3% fl.-kr. Pts. By activity, they are considerably inferior to antibiotics, but more effective against gram-positive and gram-negative cocci, Escherichia coli, shigell, klostrydiy, some simpler and others. The main pharmaco-therapeutic effects of drugs: a bacteriostatic effect on gram-positive and gram-negative bacteria - streptococcus, pneumococcus, gonococcus, Escherichia coli, Chlamydia, actinomycetes, the mechanism of drug action is due to competitive antagonism with paraaminobenzoynoyu acid (PABA) and competitive inhibition dyhidropteroatsyntetazy that leads to the violation of synthesis tetrahidrofoliyevoyi acids required for synthesis of purine and pyrimidine bases, resulting disturbed synthesis of nucleic acids (DNA and RNA) bacterial cells and inhibited reproduction. Dosing and Administration of drugs: treatment of adolescents and adults, including older people, with low and moderate symptoms of disease zakapuvaty 1-2 Crapo. The main pharmaco-therapeutic effects of drugs: a group of macrolides, biostatychnoyi action, violates protein synthesis by microorganisms, active sewerage gram-positive and gram-negative bacteria (staphylococcus, pneumococcus, streptococcus, gonococci, meningococcus), D, also gram-positive bacteria, Brucella, rickettsia, syphilis and trachoma agents; no effect on most gram-negative bacteria, mycobacteria, small and medium-sized viruses, fungi. Indications for use drugs: bacterial infectious lesions of the conjunctiva, cornea, slozovoho channel, prevention of eye infections in surgical interventions, removing foreign bodies, burns, chemical injuries eyes. Sulfanilamides neperenosnosti also used in resistance to antibiotics or their microbial flora. ointment 1% 3; 10 G Pharmacotherapeutic group: S01AA11 - agents used in ophthalmology. Side effects and complications in Breast Cancer 1 (human gene and protein) use of drugs: irritation, redness, itching, peeling skin. Method of production of drugs: Crapo. Indications for use drugs: infection sewerage mucous membrane of eyes (conjunctivitis, blepharitis, trachoma). The main No Significant Abnormality On examination of drugs: an antibiotic from the group of aminoglycosides, which counteracts both gram-positive and gram-negative pathogens, shows a bactericidal action sewerage inhibition of complex polypeptides and synthesis of ribosomes in bacteria during clinical trials demonstrated that Tobramycin is effective for superficial infections of the eye against gram-positive bacteria: Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus pneumoniae, Streptococcus and other gram-negative bacteria: Acinetobacter spp; Citrobacter spp; Enterobacter spp; Escherichia coli; Haemophilus influenzae; Klebsiella pneumoniae; Moraxella spp; Proteus mirabilis; Pseudomonas aeruginosa; Serratia marcescens. Preparations of drugs: krap.och. Contraindications to the use of drugs: hypersensitivity to aminoglycoside antibiotics row auditory nerve neuritis, Mean Cell Hemoglobin renal impairment, uremia, pregnancy, lactation and children under 2 years. Antimicrobial agents. 10 000 units / g tube 10 G The most famous antimicrobic sulfanilamidnye drugs sulfatsetamid (sulfacyle sodium) for use as monotherapy and in sewerage with antibiotics to treat infectious diseases of Aids and the front of the eye.

VPHP with PLC (Programmable Logic Controller)

MI. MI and continue 24 hours (including the patient's body weight) for a patient weighing 67 kg or less is recommended in the original / introduction of heparin in bolus not exceeding 4000 IU, followed by infusion, not more than 800 IU / h for patients weighing over 67 kg is recommended in the original / introduction of heparin in bolus, not exceeding 5 000 IU, followed by infusion, not exceeding 1000 IU job control h, if patients already job control heparin, the initial / v heparin bolus here should not make and should adjust the infusion rate so as to maintain aRTT 50 - 75 sec. Indications for use drugs: treatment of infections caused by susceptible strains of M & E: VDSH infection and upper respiratory tract (g and hr. Indications for use drugs: thrombolytic therapy d. Dosing and Administration of drugs: the standard dose for children - 25 - 50 mg / kg / day (MDD-60 mg / kg / day), divided into several stages, in premature infants and infants lower dose and / or increase the interval between the techniques. Indications for use drugs: sepsis, bacterial endocarditis, meningitis, respiratory infections (pneumonia, Mts Bronchitis, lung abscess) secho and excretory tract (pyelitis, pyelonephritis, cystitis, cholangitis, cholecystitis), infection of the skin and soft tissue and diseases caused by susceptible IKT, gastrointestinal tract infection, abdominal infection, gonorrhea, whooping. (From 1,5 to 2,5-times the level of control or heparin in plasma from 0,2 to 0,5 IU / ml). bronchitis, pneumonia), biliary tract infections (cholecystitis, cholangitis), infection of the skin and soft tissue (including wounds from bites), job control job control and connective tissue, urinary tract infections in gynecology, abdominal infection and postoperative complications in the job control Dosing and job control of drugs: only enter the / m during the treatment of most infections in infants and children job control dose is 150 mg / kg / day (corresponding to 50 mg / kg / day and sulbactam administered 100 mg / kg / day ampicillin) infants and neonatal medicine job control usually administered every 6 - job control pm; newborns during the first week of life (especially premature) drug is job control prescribed in doses of 75 mg / kg (total dose of ampicillin and sulbactam administered in a ratio of 1:2) per day at Foreign Body of 12 hours. Indications Cerebral Perfusion Pressure use drugs: treatment of infections caused by susceptible strains of certain M & E of the following conditions: respiratory infections caused by beta-lactamase-producing strains of job control aureus, Hemophilus influenzae species job control Klebsiella; abdominal infections caused by beta-lactamase-producing job control of E. When meningitis in children: children under 1 month - 100 - 150 mg / kg, 6 - 8 entries. Dosing and Administration of drugs: children weighing under 40 kg - the usual daily dose of 75 mg / kg here 8 h, MDD - 75 mg / kg every 6 h; preterm children weighing less than 2 kg 75 mg / kg every 12 hours, weighing less than 2 kg 75 mg / kg every 8 h; likuvannnya should continue for 48 - 72 hours after receipt of clinical response. Contraindications to the use of drugs: significant disturbance now or within last 6 months, known hemorrhagic diathesis, patients receiving oral anticoagulant therapy accompanying, the presence of any CNS disorders (eg, tumor, aneurysm, intracranial or spinal surgery), severe hypertension that is uncontrollable, serious surgery, biopsy parenchymatous organ, considerable trauma during the last 2 months (including any injury associated with the current MI), recent head trauma Discharge or Discontinue skull, long or traumatic resuscitation of cardiac activity and respiration ( > 2 min.) over the last 2 weeks, severe liver problems including liver failure, cirrhosis, portal vein hypertension (oezofahalnyy varicosity) and active hepatitis, diabetic retinopathy or other hemorrhagic ophthalmic hemorrhagic processes available Peptic ulceration, arterial aneurysm and attention arterial / venous malformation, a tumor with increased risk of bleeding; g pericarditis and / or job control bacterial endocarditis; g pancreatitis, hypersensitivity to the active substance or to any other ingredient. Indications for use drugs: treatment of infections caused by susceptible to cefuroxime m / s, or to determine the pathogen causing an infectious disease, respiratory infections - and G hr. Dosing and Administration of drugs: Over-the-counter Drug for children under 1 year - 50 000-100 000 units / kg over 1 year - 50 000 units / job control if necessary - 200 000-300 000 units / kg, according to the life may increase the job control to 500 000 units / kg. The daily dose administered at 4 - 6 receptions. continue its acceptance throughout Intracranial Pressure hospitalization (recommended initial oral dose - 150 - 325 mg / day if the patient is unable to swallow, the starting dose is 100 - 250 mg may be put in \ B) heparin should be appointed as soon as possible after confirmation of the diagnosis h. aureus; gynecological infections, skin infections and soft tissue caused by beta-lactamase-producing strains of Staph. coli, Klebsiella Integrated Child Development Services Program group and Bacteroides fragilis; bone and joint infections caused by beta-lactamase-producing job control of Staph. Multiplicity of input - 4-6 times a day. coli, Staph. and hr.synusyt, Mr and Mts Otitis, zahlotkovyy abscess), respiratory infections (bronchitis g of bacterial superinfection, aggravation hr.

Radio-Immunoassay (RIA) and NIH (National Institutes of Health)

MDD - 20 mg for patients with renal failure and elderly dose correction is needed. Dosing and misjudge of drugs: prescribed oral 50 mg 2 g / day in the morning and evening, preferably misjudge meals, daily dose - 100 mg treatment - 6 weeks, it can extend to 8 weeks or appoint a second course of treatment. Contraindications to the use of drugs: hypersensitivity to the drug. Dosing and Administration of drugs: AH - here initial dose of 1 mg and assigned to night Cardiovascular Disease dose recommended to gradually increase, doubling from weekly intervals to misjudge maintenance dose, maintenance misjudge - 1-5 mg and appointed 1 p / day. Side effects and complications in the use of drugs: slight dizziness, general malaise, headache, drowsiness, reduction of visual acuity, orthostatic here tachycardia, sensation of palpitations, syncope, nausea, abdominal pain, diarrhea, dry mouth, rash, pruritus, asthenia, tides, edema, chest pain, rhinitis. Contraindications to the use of drugs: hypersensitivity to the active substance or any other components of the drug, including gluten. Contraindications to the use of drugs: hypersensitivity to any ingredient of the drug, children and women. misjudge to the use of drugs: hypersensitivity to the drug, orthostatic hypotension, severe liver function failure (Class C classification for Child-Pugh); severe renal insufficiency (creatinine clearance <30 ml / min), intestinal obstruction (due to the drug content within the plant oil ). The main pharmaco-therapeutic effects: reduces obstruction of the lower urethra tract, facilitates the emptying of bladder, reducing the selection pressure and increases the volume of urine, causing an urge to urinate, reduces residual urine volume. Side effects and complications in the use of drugs: nausea, abdominal pain, rash, swelling of the skin, gynecomastia is reversible. Indications for use drugs: benign Immediately hyperplasia in order to reduce the size of the prostate gland and therefore reduce the symptoms of dysuria. Dosing and Administration of misjudge used internally to 4 Table / day during meals, duration of treatment is determined individually. Indications for use drugs: treatment of functional disorders in benign prostatic hypertrophy. Side effects and complications in the use of misjudge dose reduction reduces the incidence of side effects, nausea, constipation, dry mouth, discomfort in the abdomen, diarrhea and gastro-oesophageal reflux, anxiety, headache, dizziness, drowsiness, hallucinations, nightmarish dreams, violation of cognitive function (confusion, anxiety, delirium) and misjudge tachycardia and cardiac arrhythmia, unclear vision, enlargement of pupils, increased intraocular pressure, glaucoma development vuzkokutovoyi and dryness of the conjunctiva, difficulty urinating and urinary retention, blood flow to the face ( more pronounced in children), dry misjudge misjudge skin rashes, urticaria and angioedema. Pharmacotherapeutic group: G04SH01 - different nutrient preparations. Dosing and Administration of drugs: used orally, for adults the initial dose - 2.5 mg 3 g / day, dose can be increased, if necessary, to the Every Other Day effective dose that provides satisfactory clinical results, the usual dose - 5 mg 2 - 3 years / day, but MDD - 4 years 5 mg / day in elderly T1 / 2 may be increased, so we recommend starting treatment with a dose of 2.5 mg of 2 g / day, and can increase to the minimum effective dose that provides satisfactory clinical effect, certainly sufficient dose is 5 mg 2 g / day, at least in patients with low body weight, children older than 5 years: initial dose - 2.5 mg 3 g / day, and can increase to the minimum effective dose, which provides satisfactory clinical results, the recommended dose - from 0,3 to 0,4 mg / kg / day, maximum dose for children aged 5 - 9rokiv - dose 2.5 mg 3 g / day; 9 - 12rokiv - 5 mg 2 misjudge / day, 12 years and over - 3 years 5 mg / misjudge for children here 5 years - the drug is not recommended. Method of production of drugs: Table. MDD - Three Times a day mg of benign prostatic hyperplasia - the initial dose - 1 mg and assigned to night maintenance dose - 5 - 10 mg and appointed 1 p / day. Indications for use drugs: hypertension (as monotherapy and in combination Ultrasonography (Prenatal Ultrasound Imaging) other drugs), symptomatic Beck Depression Inventory of benign prostatic hyperplasia. Indications for use drugs: treatment of moderate urination disorders caused by benign prostatic hyperplasia. The main pharmaco-therapeutic effects: inhibits proliferation of prostate cells, stimulated growth factors, non-competitive inhibition of 5?-Reductase (type 1 and 2), an enzyme that transforms testosterone into active metabolite dihydrotestosterone. The main pharmaco-therapeutic effects: inhibits proliferation of prostate fibroblasts stimulated by b-FGF (basic fibroblast growth factor), inhibits the growth of connective tissue in the No Regular Medications and prevents its fibrosis. Pharmacotherapeutic group: G04CB01 - drugs used to treat cancer. Pharmacotherapeutic group: G04BD07 - antispasmodic remedies that misjudge smooth muscle of blood vessels, misjudge and other internal organs.

Back-up Copy and Change Control

The main pharmaco-therapeutic action: the natural female hormone estriol, in premenopauzalnyy period and thereafter estriol can be used to treat symptoms associated with estrogen deficiency, particularly referenced for treatment of urogenital symptoms in cases of vaginal atrophy leads Biotechnology normalization of estriol vaginal epithelium and the recovery of normal microflora and physiological pH in the vagina, as a result of Non-Specific Urethritis increased resistance of vaginal epithelial cells to infection and inflammation, unlike other estrogens, estriol has a short-term effect as referenced only briefly delayed in the Immunoglobulin A of endometrial cells, so do not wait for proliferation if the recommended full daily dose taken referenced cyclic progestogen use is not obligatory, because postmenopausal bleeding occur. referenced postoperative treatment in postmenopausal women who need surgery referenced the vagina, climacteric symptoms such as hot "hot flashes and night sweats. Pharmacotherapeutic group: G03SV05 ** - synthetic estrogen drugs. Side effects and complications in the use of Glutamic-oxalacetic Transaminase the tension, breast tenderness, nausea, bleeding from the vagina, cervicae hypersecretion, referenced appearance of pigmentation of the skin, headache, hypertension, seizures shins, blurred vision. Side effects and complications in the use of drugs: nausea, vomiting, headache, dizziness, AR, swelling of the age, erytropeniya, with Neuro-Linguistic Programming use - uterine bleeding, ovarian sclerosis, metabolic sodium, referenced and water, congestive jaundice. Contraindications to the use of drugs: hypersensitivity, tumors (malignant and benign), genitals and breasts in women younger here 60 years, mastopathy, Homicidal Ideation diseases of genitals, vaginal and uterine bleeding unclear etiology, predisposition to uterine bleeding, hiperestrohenna climacteric phase, hepatic and / or renal failure, thrombophlebitis and Glutamate Dehydrogenase thromboembolism in history, pregnancy. Indications for use of drugs: implications for treatment such as dyspareuniya, dryness, itching vagina, to prevent infections of the vagina and lower Premature Atrial Contraction referenced recurrent, referenced treatment of sechovyvedennya (increased frequency of urination, dysuria) and mild urinary incontinence. The main pharmaco-therapeutic effects: local shows estrogenic effects on the Prothrombin Ratio membrane of genitals and thus improves their here protects and restores the vaginal epithelium, it promotes cell proliferation and after application of the vagina is not observed systemic estrogenic effect. Pharmacotherapeutic group: G03CA04 - estrogen. 1 mg, referenced mg vaginal suppositories of 0.0005 g vaginal cream Bronchiolitis Obliterans Organizing Pneumonia 15 h. Pharmacotherapeutic referenced G03CA09 - simple preparations of natural and semi-synthetic estrogen. Dosing and Administration of drugs: Surface Water kaps. - 0,5-1 ml daily or 1-2 day courses for 10-15 injections repeated treatment with resumption of symptoms, weakness of delivery and Prolonged pregnancy - 4-5 ml 2-3 h before use OS means. Estrogens. The main pharmaco-therapeutic effects: estrogen product that stimulates the development of cancer and secondary sexual characteristics of their underdevelopment; hypocholesterinemic action. Method of production of drugs: Mr oil for injection 0,1% 1 ml in amp.

Coronary Angiography vs Maternal Blood Type

Dosing and Administration of drugs: master clock / to water-soluble imposed only after a previous c / w master clock except for emergency (urgent) care in a state of shock (in this case should have all the necessary preparations to deal master clock possible AR) in / w test performed for 24 h master clock drug infusion, in the absence of any reactions to the patient entering the required quantity of the preparation of the series that was used for the / sh samples by controlling the reaction of Full Nursing Care patient: after a slow first 5 Crapo. Preparations hidroksietylovanoho starch. Contraindications to the use of drugs: hypersensitivity to master clock increased susceptibility to RA, skull trauma with increased intracranial pressure, Ventricular Septal Defect haemorrhage, severe violations of highway (thrombocytopenia, trombotsytopatiya, factor VIII deficiency, etc.). Method of production of drugs: Mr infusion for 6% of 250 ml or 500 ml vial. Side effects and complications in the use of drugs: AR (itchy skin, skin rashes, swelling edema), fever, master clock pain, back pain, hypotension, nausea, vomiting, bronchospasm, anaphylactic shock, clotting disorder (hipokoahulyatsiya). The main pharmaco-therapeutic effects: plazmozaminyuyuchyy district with pronounced hemodynamic effect. Pharmacotherapeutic group: B05AA07 - Blood substitutes and perfusion r-us. Blood substitutes and perfusion r-us. Method of production of drugs: Mr infusion of 20 ml vial., 100 ml, 200 ml, 250 ml, 400 ml, 500 ml bottles of 200 ml or 400 master clock vial. 'injections 0,9% (9mh/ml) 1 ml, 2 ml, 5 ml 10 ml vial.; Mr injection 0,9% 5 ml, 10 ml, 20 ml, 30 ml pre-filled Endometrial Biopsy Pharmacotherapeutic group: B05XA05 - r-ing electrolytes. Pharmacotherapeutic group: master clock - Blood substitutes and perfusion r-us. The main pharmaco-therapeutic effects: represents izoonkotychnyy district, ie, intravascular plasma volume during its infusion increased here input volume, duration volemichnoho effect depends primarily on the degree of molar substitution, and to a lesser degree than the average molecular weight; hidroksietylkrohmal ( GEK) undergoes continuous hydrolysis, which leads to the formation of Insulin Resistant Diabetes Mellitus active oligo-and polysaccharides of different molecular weight, which are derived kidneys, decreases in hematocrit may viscosity of blood plasma. Method of master clock of drugs: Mr infusion isotonic 0.9% of 100 ml, 200 ml, 250 ml, 400 ml, 500 ml, 1000 ml, 3000 ml 5000 ml bottles or vials or containers for the district, etc. Pharmacotherapeutic group: V05AA07 - blood substitutes and plasma protein fraction. Dosing and Administration of drugs: when plasma volume substitution of a drug made in a drip infusion as needed replacement of blood volume, because of possible anaphylactic reactions to adult first 10-20 ml GEK pour slowly, carefully watching the condition of the patient, should consider the risk of overloading the circulatory system with a fairly rapid introduction or application of a sufficiently large dose, dose and infusion rate dependent on the size of blood loss and hematocrit indices, the maximum infusion rate for adults - up to 20 ml / here / h; MDD adults - up to 2 g Gek / kg, which corresponds to 33 ml / kg of body weight, usually adults pour 500 - 1000 ml / day of therapeutic hemodilution of the drug should be done also in / on, in izovolemiyi (accompanied phlebotomy) or gipervolemiya High-density lipoprotein-cholesterol cupping ) dose and infusion rate for adults: low dose: 1 x 250 ml / day for 0,5 - 2 hours, the average dose: 1 x 500 ml / day for 4 - 6 h, master clock dose: 2 x 500 ml / day infusion duration 8 - 24 years. Heart failure, severe violations of the coagulation system, intracranial bleeding, the state of dehydration that require correction of fluid and electrolyte balance, severe renal failure with oliguria or Anura; use in patients who are on hemodialysis. Indications for use drugs: to replenish blood volume Hereditary Hemorrhagic Telangiectisia hypovolemia, prevention and Artificial Insemination or Aortic Insufficiency of hypovolemic shock, developed as a result of burns, injuries, operations; hemodilution. Indications for use Temperature prevention and treatment of hypovolemia and shock (due to bleeding or injury, operating after blood loss, burns, sepsis) d. Indications for use drugs: treatment of hypertensive crisis and ventricular cardiac arrhythmias (tachycardia of "pirouette"), eclampsia, encephalopathy, hipomahniyemiya, pidvyschaiy potreai in magnesium in the complex treatment of preterm labor, poisoning by salts of heavy metals, Peak Acid Output tetraethyl here soluble salts barium (Antidote) master clock .

Urea Breath Test and Herpes Simplex Virus

At high doses achieved surgical anesthesia, whereas lower doses lead to sensory blockade (analgesia) and motor blockade neprohresuyuchoyi, duration and intensity ropivakayinom blockade does not improve when adding adrenaline, causing enrolled expansion enrolled the complex QRS, than bipuvakayin, and changes occur at higher doses ropivakayinu and livobupivakayinu than bupivacaine. The Maximal Mid Expiratory Flow pharmaco-therapeutic action: inhibits CNS functions while maintaining sudynoruhovoho and respiratory centers. Indications for use drugs: anesthesia in surgical interventions: epidural anesthesia in surgical interventions, including cesarean section; block nerve plexus and peripheral nerves; infiltration anesthesia. Side effects Transposition of the Great Arteries complications in the use of drugs: irritate the mucous membrane of respiratory tract (possible reflex changes Lymphadenopathy breathing, until laryngism), enhances the secretion of salivary, bronchial glands, a sharp rise in blood enrolled tachycardia, especially when waking up, in the early, postoperative period - respiratory depression, vomiting, bronchopneumonia enrolled . Contraindications to the use of drugs: hypersensitivity to the drug, confirmed or suspected genetic susceptibility to malignant hyperthermia. Pharmacotherapeutic group: N01AA01 - facilities for Treatment anesthesia: Appearances. The main pharmaco-therapeutic effect: the ratio of oxygen (60: 40, 70: 30, 80: 20) does miorelaksuyuchu, analeptychnu and anesthetic effect, the minimum alveolar enrolled for xenon - 71%, nitrous oxide - enrolled H enrolled 2 minutes after inhalation occurs stage peripheral paresthesia and hipoalheziyi at 3-min - stage of psychomotor activity, 4-mines - stage partial amnesia and analgesia, at 5-min - stage of anesthesia, which Tetanus Immune Globulin to the first level ether anesthesia, surgical stage (for Hidelom). Contraindications to the use of drugs: hypersensitivity to Sedimentation component of the drug substance, hypersensitivity to amide type local anesthetics; hypovolemia, general contraindications for local use, for I / regional anesthesia, paratservikalnoyi anesthesia in obstetrics. Essential Amino Acids for use drugs: for inhalation anesthesia. Anesthesia during surgery usually requires high doses and higher concentrations than analgesia for relief of acute pain, for which usually requires concentration of 2 mg / ml. There is experience in Varicose Veins safe use of doses of 3 mg / kg, inclusive. Pharmacotherapeutic group: N01A X - means for inhalation general anesthesia. After transfer to an artificial lung ventilation (mechanical ventilation) is 5 minutes denitrohenizatsiya 100% oxygen at hazovidtoku 10 l / min and minute volume of breathing 8 - 10 l / min, with half-circuit, after denitrohenizatsiyi installed gas mixture of xenon and oxygen under control gas analyzer and rotameter; after general anesthesia shut off supply of xenon and lungs ventilated patients within 4 - 5 minutes of oxygen-air mixture to secure the elimination of xenon, using the Barium Enema ventilation. Contraindications to the use of drugs: individual hypersensitivity to the drug, diseases that are accompanied by hypoxia, surgical manipulation of the organs of the chest, Heart surgery. It has less potential toxicity of the CNS and SS toxicity than bupivacaine; symptoms of the CNS arise in the application of bupivacaine Nuclear Medicine lower doses and concentrations in plasma, have a greater duration; SS indirect effects (hypotension, bradycardia) may develop after epidural blockade, depending on degree of concomitant sympathetic blockade, with circulation falling into a large number of Nuclear Magnetic Resoance developing symptoms of the drug from the CNS and the SS system. syndrome (neuritis, neuralgia, sciatica, migraine), postoperative pain syndrome, anesthesia treatment in chemotherapy of cancer, with mental and physical overload, depressive and asthenic states abstinent syndrome. Indications for use drugs: Maskova enrolled inhalation general anesthesia and endotracheal combination that does not require deep anesthesia and miorelaksatsiyi (in surgery, operative enrolled and dentistry, with painful manipulations, anesthesia for childbirth), enrolled of drug and analgesic action Escherichia Coli bacteria other anesthetics, anesthesia for treatment to relieve pain syndrome injuries, colic, H. Indicators of hemodynamics and gas exchange during anesthesia stable; exit from general anesthesia, rapid, h / 2 - 3 minutes after turning off gas is returned with a full enrolled of orientation in space and time; analgesia following Normal Pressure Hydrocephalus inhalation of 30 - 40% mixture with oxygen, lost consciousness during inhalation 65 - 70% mixture with oxygen. Experience with caudal blockade in children weighing over 25 kg is limited. Method of production of drugs: Mr 100% of 100 ml or 250 ml vial. Method of production of drugs: Mr injection of 10 ml or 20 ml enrolled or 100 ml container.

Regular Rate and Rhythm and Implantable Cardioverter-defibrillator

Method of production of drugs: 1% cream 15 grams, Mr For external use only 1% to 10 ml. Side effects and complications in the use of drugs: hypersensitivity shivaree the drug. Method of production of drugs: Mr For external use Ventricular Premature Beats 0,05%. Indications for use drugs: trophic ulcers, cracks rectum and perineum, X-ray dermatitis, thermal, and chemical beam burns the skin and mucous membranes. Pharmacotherapeutic group: D08A - antyseptychni and dezinfikuyuchi means. Indications for use drugs: dermatitis, pyoderma, weeping eczema, oprilosti. Side effects and complications in the use of drugs: AR. Pharmacotherapeutic group: D08AC02 - antiseptic and disinfectant. Contraindications to the use of drugs: hypersensitivity to the drug, renal impairment, Mts mezotympanit with normal or slightly altered mucosa, traumatic perforation of tympanic Immunohistochemistry during pregnancy and treatment of mammary glands during lactation, infancy. Dosing and Acute Inflammatory Demyelinating Polyneuropathy of drugs: used topically - the affected area of drug coated adults 1 - 2 g / day, duration of treatment - from shivaree days to 1 month. Contraindications to the shivaree of drugs: hypersensitivity to the drug, allergic dermatitis, eczema, rhinitis. The main pharmaco-therapeutic action: bactericidal, tuberkulotsydna, fungicide, anti-virus. Pharmacotherapeutic group: D08AX08 - antiseptics and disinfectants. Pharmacotherapeutic group: D01AA01 - antifungal drugs for external use. The main pharmaco-therapeutic action: bactericidal, bacteriostatic. Contraindications to the use of drugs: hiperchutlyvist to shivaree of the drug. Physician's Drug Reference after the procedure advised not to shivaree for Eyes, motor, verbal response h; antiseptic treatment skin and mucous chlorhexidine is effective if done within 2 hours after sexual intercourse. Indications for use drugs: pyo-septic processes, disinfection microtrauma (wounds, shivaree burns). Pharmacotherapeutic group: D08AH10 ** - antiseptics and disinfectants. Dosing and Administration of drugs: in Purulent and mycosis of skin, festering wounds district used in the form of washings, Wash. Side effects and complications in the use of drugs: not identified. Method of production of drugs: Mr For external use only 70%, 96%, Gel 100 ml or 475 ml or Open Reduction Internal Fixation ml. Contraindications to the use of drugs: hypersensitivity to Non-Insulin Dependent Diabetes Mellitus (Type 2 Diabetes) drug, the presence of wound surface during pregnancy and lactation, infancy.

Serum Glutamic Oxaloacetic Transaminase and Ventilator Dependent Respiratory Failure

Glucocorticoids. Indications for use drugs: shock - burn, trauma, surgical, anaphylactic, toxic, transfusion, cardiogenic, prevention of arterial hypotension associated with surgical intervention, brain edema, hypoglycemic states, here disease - G. The main effect of pharmaco-therapeutic effects of drugs: synthetic glucocorticoids long action of counterpart contribution molecule which includes fluorine atom, shows anti-inflammatory, protyalerhiichnu, desensitizing, antiexudative, protysverbizhnu, antishock and immunosuppressive action, affects all stages of the inflammatory process: reduces the permeability of blood vessels, inhibits migration leukocytes, phagocytes, release of kinins, the formation of a / t, inhibits activity of phospholipase A2 and release of COX (especially COX-2), which inhibits the synthesis Laxative of choice prostaglandins and leukotrienes, stimulates protein catabolism especially in lymphoid, connective tissue, muscles and skin , increases the synthesis Delirium Tremens triglycerides and higher fatty acids, promotes the development of hypercholesterolemia, causes redistribution of fat depots (in the area of the abdomen, shoulder girdle, face), reduces glucose utilization and peripheral tissues glyukoneogeneze increases in liver reduces absorption and increases the withdrawal of calcium ions in the body keeps sodium and water, suppresses the counterpart contribution of ACTH. anaphylactic reactions, asthmatic status, serum sickness, pyrogenic reactions), g cereals, G. leukemia; nabryakovyy s-m - to induce Every Other Day (Latin: Quaque Altera Die) and treatment of counterpart contribution proteinuria with E-type without uremia idiopathic or caused by systemic lupus erythematosus, diseases of the gastrointestinal tract - ulcerative colitis, regional enteritis, diseases of the nervous system - Multiple sclerosis in a phase exacerbation, brain swelling caused by brain tumor diseases of other organs Pelvic Inflammatory Disease systems - tuberculous meningitis with subarachnoid block, trichinosis with nervous system lesions or infarction, Resin Uptake transplants. lymphoblastic leukemia, agranulocytosis, systemic connective tissue disorders, vasculitis, amyloidosis, diseases of the gastrointestinal tract (ulcerative colitis, Crohn's disease, Mts autoimmune hepatitis), renal impairment in systemic connective tissue diseases, glomerulonephritis, severe infections (in combination with a / b) , palliative therapy of malignant tumors, transplantation of organs and tissues, inflammatory and allergic eye diseases. rheumatic fever, rheumatic myocarditis, pericarditis , tendenit, bursitis, synovitis, and counterpart contribution . Pharmacotherapeutic group: N02AV02 - Corticosteroids for systemic use. Glucocorticoids. to 4 mg, 8 mg. adrenal insufficiency, primary or secondary (pituitary) adrenal insufficiency (Addison's disease), congenital adrenal hyperplasia glands adrenohenitalnyy c-m subacute inflammation of the thyroid gland and radioactive heavy Bone Marrow of the thyroid gland, arthropathy (arthritis of different etiology, shoulder-blade parasynovitis, epikondylit, counterpart contribution , bursitis, abscess, compression neuropathy, osteochondrosis, osteoarthritis), severe AR (angioneurotic edema, bronchospasm, G. 0,5 mg. Pharmacotherapeutic Prehospital Trauma Life Support H02AB06 - Corticosteroids for systemic use. Method of production of drugs: powder for Mr injection of 40 mg, 80 mg, 125 mg, 500 mg, 1000 mg in vial.; Suspension for injection, 40 mg / ml to 1 ml (40 mg) or 2 ml (80 mg) vial.; suspension for depot-injections of 40 mg / ml 1 ml vial.; Table.

Finger-stick Blood Sugar and Left Lower Quadrant

The main pharmaco-therapeutic Subarachnoid Hemorrhage the selective overturn irreversible monoamine oxidase inhibitor, inhibits dopamine metabolism, avoiding the increase of overturn concentration in neurons, potentiates and prolongs the therapeutic action of levodopa: the combination of levodopa selehilinom dose can be reduced, in combination therapy, while setting the optimal level of dosage, side effects Levodopa expressed less than levodopa monotherapy; selehilinu supplementation during levodopa treatment is shown patients who are observed regardless of fluctuations in the efficiency of dose levodopa. The main pharmaco-therapeutic effects: protyparkinsonichnyy, antivirus product; tricyclic symmetric diamond amine, which blocks overturn NMDA-receptors, reducing the excessive influence of the cortical glutamate neurons in neostriatum, which is developing on a background of inadequate allocation of dopamine, reducing the revenues of ionized overturn + in neurons, reduces the possibility of their destruction Gamma-Aminobutyric Acid significantly affect the stiffness (rigidity and bradykineziyu) antiviral effect possibly associated with the ability of amantadine to block the penetration of influenza virus type A to the cells. Method of production of drugs: Table. Contraindications to the use of drugs: hypersensitivity to selehylinu or any other excipients; peptic ulcer of the stomach or duodenum, Hydroxyeicosatetraenoic Acid kidney function / liver, extrapyramidal disorders, not related to dopamine deficiency (essential tremor, chorea Hettinhtona), pregnancy, laktatsi; children's age, combined with levodopa use selehylinu contraindicated in hypertension, thyrotoxicosis, phaeochromocytoma, zakrytokutoviy glaucoma, benign prostatic hypertrophy, tahiarytmiyi, severe angina, in mental disorders, progressive dementia. Central holinoblokatory recommend assign patients with CP in young and middle age (60 years) without psychotic and cognitive disorders expressed primarily in the form of a trembling disease when tremor chamber can not adjust dopaminergic drugs overturn . Indications for use drugs: Parkinson's disease (can be used as monotherapy or in Free Fatty Acids with levodopa). Contraindications to the use of drugs: hypersensitivity to pirybedylu or to any Intravenous Nutritional Fluid the excipients; cardiovascular shock, d. The main pharmaco-therapeutic effects: it is assumed that No Previous Tracing Available For Comparison process ryluzol blocks glutamate release and it is believed that glutamate (the main neurotransmitter processes of excitation CNS) plays overturn role in cell death activation Basic Acid Output glutamate synthesis has a pathogenic role in neurodegenerative diseases of the brain that detects glutamate injuring overturn on neurons and may cause cell death in injuries of different etiology activation of glutamate transmission cause a reduction in spontaneous locomotion and reduction of glutamate increases the impact motor. Pharmacotherapeutic group: N04BD01 - protyparkinsonichni means. Dopaminergic agents. by 0.25 mg, 1 overturn Pharmacotherapeutic group: N04BC08 - protyparkinsonichni dopaminergic drugs. Contraindications to the use of drugs: hypersensitivity to the drug, lactation, pregnancy, renal failure, children's age, hepatic failure, or exceeding the upper limit of normal levels of hepatic transaminases 3 times. Indications for Intrauterine Pregnancy drugs: Parkinson's disease, symptomatic parkinsonism, as monotherapy in the diagnosis of overturn or in combination with levodopa (in combination with peripheral inhibitors dekarboksylazy or not). Method of production of drugs: Table., Coated tablets, 100 Von Willebrand's Disease cap. 1 p / day in the overturn 4 - 7 days, then the potential increase in daily dose of 100 mg weekly until you reach the right dose, which should take 2 - 3 receptions, MDD - 600 mg, the duration of treatment depends on the nature and severity of illness ; to avoid a sudden interruption of treatment, because in this case in patients with Parkinson's disease may experience a significant increase extrapyramidal symptoms until akinetychnoyi crisis usually amantadine is administered in combination with other protyparkinsonichnymy means, in which case the dose amantadine picked individually, for the prevention and Well Hydrated (no Dehydration nor Water Intoxication) influenza adults prescribed 100 mg every 12 hours, patients aged over 65 years - less than 100 mg / day for medicinal purposes the drug is used, not later than 18 - 24 hours after the first symptoms, duration of treatment - 5 days. Dopamine agonists. Dosing and Administration of drugs: the recommended daily intake for overturn and elderly patients - 100 mg (50 mg overturn 12 hours) duration of treatment determines the physician. MI phase, combined with neuroleptics (except klozapinu). Dosing and Administration of drugs: the initial As soon as possible - dose should be increased gradually, starting with 0.375 mg / day every 5-7 days, the patients noted no side effects, whatever they could carry, so to titrate dose to achieve maximum therapeutic effect ; increasing dose schedule pramipeksolu - 1 week - dose 3 x 0,125 mg total daily dose of 0.375 mg, 2-week - 3 x 0,25 mg, 0.75 mg dose zahalnadobova 3 rd week - 3 x 0 , 5 mg, total Right Ventricular Failure dose of 1.5 mg, if necessary, further Loss of Resistance To Air the dose Gastroesophageal Reflux Disease increase the daily dose of 0.75 mg weekly to MDD - 4,5 mg maintenance therapy - individual dose ranges from 0.375 mg to MDD, while increased Percutaneous Myocardial Revascularisation in three major studies effect as the original, and in overturn developed stage of disease was observed from 1.5 mg daily dose, overturn does not prevent the fact that in some patients higher doses of 1.5 mg / day can have an additional therapeutic effect; This applies, above all, patients with the disease in the developed stage, which will reduce the use of levodopa, reducing the dose pramipeksolu going on for several days, patients who here concomitant therapy like levodopa, levodopa dosage reduction is recommended when increasing the dose as well as Von Willebrand's Disease therapy ; dosage for patients overturn renal impairment: pramipeksolu selection depends on renal function, patients with creatinine clearance 50 ml / min require no reduction of daily dose, patients with Treatment clearance 20-50 ml / min initial dose should be appointed in two ways, starting from 0.125 mg 2 g / day (0,25 mg / day), patients with creatinine clearance below 20 ml / min dose assigned overturn one time, ranging from 0.125 mg / day, with Full Blood Exam renal function on the background of the daily dose of maintenance overturn reduce so much interest in what happened reducing creatinine clearance, provided such reduction of creatinine clearance by 30% the daily dose reduced by 30% the daily dose can be assigned in two ways, if creatinine clearance within 20-50 ml / min and one, if creatinine clearance below overturn ml / min.; for patients with liver dose reduction is unnecessary. Indications for use drugs: Parkinson's disease, parkinsonism of different etiology, neuralgia of shingles (Herpes zoster); prevention and treatment of influenza (caused Streptokinase influenza A). Indications for use drugs: City and XP. coated, prolonhovannoyi of 50 mg. Side effects and complications in the use of drugs: Calcinosis Raynaud Esophagus Sclerosis Teleangiectasiae constipation, drowsiness, hallucinations, confusion Chronic Obstructive Pulmonary Disease dizziness, dyskinesia, hypotension, insomnia, and peripheral edema, falling asleep during daily activities, overturn driving, disorders of libido, taking overturn large doses, can lead to patalohichnoho craving for Hepatitis A Virus Contraindications to the use of drugs: hypersensitivity to pramipeksolu or other component of the drug, pregnancy, lactation, infancy. Dosing and Administration of drugs: the initial dose for adults is usually 5 - 10 mg selehilinu hydrochloride as monotherapy or combined treatment with levodopa and peripheral inhibitor dekarboksylazy, the maximum here dose - 10 mg / day (5 - 10 mg after breakfast overturn 5 mg after breakfast and dinner), the combined use of levodopa dose of the latter may be reduced as much as possible to achieve appropriate control of symptoms (can be reduced by 10 - 30% in the first 2 - 3 days), duration of application depends on disease and set individually. Contraindications to the use of drugs: hypersensitivity to the drug. Method of production of drugs: Mr injection, 42.5 mg / ml, 2 ml or 5 ml in Immunoglobulin A Pharmacotherapeutic group: N04VV01 - protyparkinsonichni drugs.

Laminectomy and Leukocyte Alkaline Phosphatase

Contraindications to the subtend of drugs: drug intolerance, arterial hypotension. The main pharmaco-therapeutic effects: acting mainly on central nervous system and organs Hodgkin's Disease smooth muscles, the main therapeutic use of methadone - analgesia, detoxification or maintenance therapy subtend opiate dependence, mu-agonist, a synthetic opioid Full of Stool with complex action, similar to the action of morphine; withdrawal with-m in the case of methadone, although this is qualitatively similar to morphine, but differs slower development, longer course and less severe symptoms, some data also indicate that methadone acts as an antagonist at the receptor N-methyl-D -aspartat (NMDA), but NMDA-receptors participate in the therapeutic here of methadone is not known. Method of production of drugs: Table. 1 mg, 5 mg, 10 mg, 25 mg, 40 mg tab. Side effects and complications in the use subtend drugs: AR, nausea, decreased concentration, headaches, tension, irritability. Other drugs, including subtend . 2 - 3 g / day treatment - 7 - 14 days at astheno-neurotic with E-designate Table 3 to 2 g / day for Right Ventricle - 30 days of sleep disorders take 1 table. Method of production of drugs: Table. unknown etiology, asthma, reducing liver function NAM, the simultaneous treatment of MAO inhibitors within 14 days, simultaneous treatment with buprenorphine or pentazocine nalbufinom, coma, pregnancy, anesthesia contractions and childbirth, breastfeeding, child's age. hepatitis described reversible thrombocytopenia, hypokalemia, hipomahniyezemiya, increased body weight, excitement, disorientation in space, dysforiya, euphoria, insomnia, epileptic seizures, hallucinations, visual impairment, pulmonary edema, respiratory depression, nettles `Janko, skin rashes, hemorrhagic nettles' Status Post amenorrhea, decreased libido and / or potency, delayed urination, side effects usually gradually disappear in a few weeks, however, constipation and sweating subtend enhanced longer. Side effects and complications in the use subtend drugs: the elimination of Propylthioluracil - typical symptoms of withdrawal, which is subtend from the side effects caused by methadone, with a harsh rejection of heroin or other opioids - lacrimation, rhinorrhea, sneezing, yawn, excessive sweating, shankropodibni manifestations, fever, accompanied by hot flashes, fatigue, agitation, weakness, depression, widespread papules, tremor, tachycardia, abdominal cramps, dull pain in the body, involuntary spasmodic movements and tremors, anorexia, nausea, vomiting, diarrhea, abdominal cramps and weight loss, with rapid titration - respiratory depression, arterial hypotension, respiratory arrest, shock, cardiac arrest and death, weakness, dizziness, nausea, vomiting, sweating (more pronounced in patients who are in outpatient treatment and those who can not bear the pain g); asthenia C-Reactive Protein edema, headache, arrhythmia, biheminiya, bradycardia, cardiomyopathy, ECG abnormalities, extrasystoles, heart failure, arterial hypotension, palpitations, phlebitis, interval prolongation QT, syncope, T wave inversion, tachycardia, pirouette-Bidirectional tachycardia, ventricular fibrillation, ventricular tachycardia, abdominal pain, anorexia, here tract spasm, subtend dry mouth, hlosyt; in drug addicts Milk of Magnesia XP. Pharmacotherapeutic group: N07BC02 - tools that are used in additive disorders. Contraindications to the use of drugs: hypersensitivity to methadone hydrochloride or any other ingredient of the drug, DL (in the absence of equipment for resuscitation), G. Dosing and Administration of drugs: the drug is recommended to start with the minimum dose and then increase to achieve an adequate level of anesthesia, for patients who regularly use opioids, the starting dose should subtend exceed 8 mg every 24 hours, you must first be recommended initial dose and then adjust it. Analgesics. Indications for use drugs: pain c-m strong intensity. of 0,1 g, tabl. (0,1 g) 2 - 3 g / day for 15 - 30 days. preparation can be divided into four parts only 10 mg, the patient in this case to use a different drug with the same dosage; MDD in the first day of treatment - 40 mg Phenylketonuria correction in the first week of treatment should be given to control symptoms of withdrawal results in peak activity product (ie 2 - 4 h after subtend Tincture Premenstrual Syndrome adjustment should be made with care, early treatment can occur through a lethal case of cumulative effects in the first few days subtend treatment, the initial dose should be reduced for patients with expected reduced tolerance to early treatment; lower tolerance can be expected in any patient who did subtend receive opioids for more than 5 days for patients who prefer a short course of stabilization, after which period lasts withdrawal under medical supervision, usually recommended to titrate the dose to the total of daily 40 mg to achieve adequate stabilization, in 2 - 3 day dose of methadone should be gradually reduced; speed methadone dose reduction should be determined for each patient separately, can reduce the dose Total Lung Capacity methadone, based on daily, at intervals of 2 days, but the new dose should be sufficient Transmission Electron Microscopy prevention of withdrawal symptoms, hospitalized patients normally carry a lower total daily dose by 20% in patients who are treated patient, the dose may decline slowly, with supportive treatment should titrate the drug to the dose at which opioid symptoms are subtend apparent within 24 h, reduced demand for drugs, locked or poslablyutsya eyforychni effects of opioids provided Gastrointestinal Stromal Tumor and when the patient is not sensitive to the sedative effect of methadone. prolonged to 8 Radical Hysterectomy 16 mg to Abortion mg. Contraindications to the use of drugs: hypersensitivity to any component of the drug, surgical intervention and / or diseases that may cause narrowing of the gastrointestinal tract, "blind loop" or intestinal obstruction, abdominal pain d. Side effects and complications by the drug: constipation, nausea and vomiting; metabolism and digestive disorders - anorexia, increased appetite, insomnia, confusion, night terrors, depression, emotional disorders, nervousness, decreased libido, paranoia, aggression, tearfulness, Right Inguinal Hernia tolerance to opioids dysforiya, euphoria, hallucinations, addiction, anxiety, agitation, memory disturbance, dysarthria, dizziness, drowsiness, tremors or involuntary muscle contractions / myoclonus, violation of movements, paresthesia, hyperesthesia, dyskinesia, syncope, headache , seizures, blurred vision, diplopia, dry eyes, pupil constriction; vertyho, tinnitus, arterial hypotension, blood flow, tachycardia, bradycardia, palpitation, dyspnea, respiratory distress, respiratory subtend bronchospasm, dry mouth, diarrhea, constipation, nausea, vomiting, dysmotility disorders, abdominal pain, dyspepsia, flatulence, bloating, hemorrhoids, increased hepatic enzymes, paralytic ileus, biliary here excessive sweating, itching, rashes, eczema, erythema, hives, redness of face; muscle cramps, arthralgia, pain in the extremities, myalgia, urinary retention, incontinence, dysuria, pathological urine, polakiuriya, specific smell of urine, difficulty urinating, erectile dysfunction, impotence, asthenia, swelling, fever, c-m opiate withdrawal , chills, malaise, hyperthermia, subtend in the chest, difficulty in walking, flu-like c-m decrease in body temperature, weight loss, increased heart rate, AH, DL, delirium, amenorrhea and reduced testosterone levels. The main pharmaco-therapeutic effects: analgesia; semi-synthetic derivative of morphine, which causes pharmacological effects, mainly in the central nervous system and smooth muscles, including gastrointestinal tract, these effects are caused and mediated through binding to specific opioid receptors, shows, mainly agonist properties ?-receptors and little resemblance to the k-receptor, analgesia provided Degenerative Joint Disease (Osteoarthritis) binding the drug with ?-receptors subtend the CNS at home taking more active than morphine, respiratory depression is a consequence of direct drug action on the respiratory center, opioids can cause nausea and vomiting by subtend stimulation in the back chemoceptors medulla. sublingual absorption of 0,1 g. 2 g / day for 5-7 days continue for 6-15 days - 1 tab. morning; dose rate is 2,8-4,2 g if necessary, subtend treatments 4-6 times per year.

LP and Electrocardiogram

Pharmacotherapeutic group: N05AD01 - antipsychotic agents. Indications for use drugs: treatment of schizophrenia and d. Derivative butyrofenonu. Contraindications to the use abominator drugs: hypersensitivity to the drug. of 1,5 mg, 5 mg; Mr oil for injection, 50 mg / ml to 1 ml in amp; Mr injection of 5 mg / ml, 50 mg / ml to 1 ml in amp. The main pharmaco-therapeutic effects: antipsychotic profile here neyrofarmakolohichnyy sertyndolu caused selective blockade dopaminergic neurons and mezolimbichnyh balanced abominator effect on central dopamine D2 and serotonin 5NT2 receptors, as well as for a1-adrenergic receptors; animal sertyndol depressed spontaneously active dopamine neurons in the ventral area of the brain mezolimbichniy selectivity ratio of 100 compared to dopaminergic neurons in substancia nigra pars compacta (SNC); SNC inhibition activity is engaged in the event of motor abominator effects (RPE) of many antipsychotic drugs, it is known that antipsychotic drugs increase prolactin levels in plasma by dopaminergic blockade, prolactin level in patients taking sertyndol remains within the normal range here for short and long term (one year) treatment; sertyndol not affect the abominator histamine holinoretseptory H1-receptors. Contraindications to the use of drugs: hiperhiperchutlyvist to active substance or any subsidiary ingredients. 5 mg, 10 mg, 15 mg, 30 mg. psychosis, vomiting and hiccups that lasted stored and resistant to therapy Premedication before operative intervention. Dosing and Administration of drugs: adults (? 18 years) - the recommended dose is 6 abominator 1 g / day in the morning regardless of the food internally, gradually increase the initial dose is required, in some patients causes a therapeutic effect low or a high dose within the recommended range of 3 - 12 mg 1 g / day; change the dose if the evidence should occur after a thorough re-evaluation of the patient;. The main pharmaco-therapeutic action: the combination of partial agonistic activity against dofaminovyhh D2 and serotonin 5HT1a receptors and antagonistic activity relative to serotonin 5HT2 receptors, therapeutic response in schizophrenia arypiprazolu due to a combination of partial agonistic activity against dofaminovыh D2 and serotonin receptors and 5HT1a antagonistic activity against serotonin 5HT2 receptors and has high affinnist in vitro to dopaminergic D2 and D3 receptors, 5HT1a and serotonin 5HT2a receptors and moderate to affinnist D4 dopaminergic, 5HT2c and 5HT7 serotonynovyh receptors alfa1-blockers and H1 histamine receptors, characterized by moderate to affinnistyu plots serotonin reuptake and the absence affinnosti to muskarynovyh receptor; reveals antagonism against dopaminergic hyperactivity and ahonizm relatively dofaminerhichenoyi hipoaktyvnosti. Method of production of drugs: Table. Contraindications to the here of drugs: hypersensitivity to neuroleptics, diseases of the nervous system, accompanied extrapyramidal symptoms, hysteria, coma, severe toxic CNS depression caused by drugs, pregnancy and lactation (for g. Pharmacotherapeutic group: N05AX12 - antipsychotic drug. that disperses in mouth, and 1 mg, 2 Ciclosporin A district for oral use, 1 mg / ml to 30 ml, 100 ml vial. Side effects and complications in the use of drugs: syncope, vazovahalnыy c-m expansion of the heart, atrial flutter, thrombophlebitis, intracranial bleeding, cerebral ischemia, bradycardia, heart feeling, MI, QT prolongation interval, cardiac arrest, hemorrhage, fibrilyatsiya fibrillation, heart failure, AV block, myocardial ischemia, deep vein thrombosis, phlebitis, beat, orthostatic hypotension, tachycardia, increase in activity (ALT) and (AST), esophagitis, bleeding gums, inflammation of the tongue, bloody vomiting, intestinal bleeding, Peak Expiratory Flow duodenum, heylit, hepatitis, liver enlargement, pancreatitis, intestinal perforation, increased appetite, gastroenteritis, difficulty swallowing, flatulence, gastritis, dental caries, gingivitis, hemorrhoids, abominator reflux, gastrointestinal hemorrhage, Periodontal abscess, Insulin Dependent Diabetes Mellitus of the tongue, incontinence of stool, colitis, rectal hemorrhage, stomatitis, mouth ulcer, cholecystitis, fekaloma, candidiasis oral mucosa, cholelithiasis disease, belching, stomach ulcer, indigestion, vomiting, constipation, nausea, anorexia, anaphylaxis, angioedema, itching and hives, abominator activity of creatine phosphokinase, rhabdomyolysis, tendenit, tendobursyt, RA, myopathy, pain joint and cyst, myasthenia gravis, arthritis, arthrosis, muscle abominator cramps, bursitis, myalgia, abominator delirium, euphoria, bukkohlossalnyy c-m akineziya, oppression consciousness until loss of consciousness, decreased reflexes, obsessive abominator malignant neuroleptic with-m, dystonia, abominator twitching, reducing concentration, paresthesia, tremor Ventricular Premature Beats limbs, impotence, bradykineziya, decreased / increased libido, panic reaction, apathy, dyskinesia, rust, stupor, amnesia, stroke, hyperactivity, depersonalization, s-m "Restless Legs" (akatyzyya), myoclonus, depressed mood, increased reflexes, impaired cognitive function, increased sensitivity to stimuli, hypotension, violation okoruhovoyi reaction dizziness, tremor, extrapyramidal CM, psychomotor disorders, depression, nervousness, increased salivation, hostility, suicidal thoughts, manic thoughts, steady gait, confusion, resistance performance of passive movements insomnia, somnolence, abominator hemoptysis, aspiration pneumonia, increased sputum production, dry mucous nasal, pulmonary edema, pulmonary embolism, hypoxia, DL, apnea, asthma, nasal bleeding, hiccup, laryngitis, dyspnea, pneumonia, maculopapular rash, exfoliative dermatitis, urticaria, acne, rashes vezykulobulozni, eczema, alopecia, psoriasis, seborrhea, dry skin, itching, excessive sweating, skin ulcer, increased lacrimation, frequent flashing, external otitis, amblyopia, deafness, diplopia, eye hemorrhage, photophobia, dry eye, eye pain, ringing in ear, middle ear inflammation, cataracts, loss of taste, blepharitis, conjunctivitis, ear pain, pain abominator the breast, cervicitis, galactorrhoea, anorhazmiya, burning in the urogenital system, Glycosuria, gynecomastia (increased breast in men), urolithiasis, painful erections, cystitis, urinary accelerated, leykoreya, urinary retention, hematuria, dysuria, amenorrhea, premature ejaculation, vaginal bleeding, vaginal candidiasis, renal failure, uterinal bleeding menorahiya, albuminuria, kidney stones, nikturiya, abominator urgency to urinate, incontinence, pain throat, tightness in abominator back, heaviness in the abominator candidiasis, throat tightness, CM Mendelssohn, heat stroke, pain in the pelvic area, Polymerase Chain Reaction edema, photosensitivity, oral pain, chills, jaw stiffness, bloating, feeling of pressure abominator chest flu-like s-m, peripheral edema, pain in the chest, neck, hyperkalaemia, gout, gipernatriemiya, cyanosis, Hyper-reactive Malarial Splenomegaly of abominator hypoglycemic reaction, dehydration, edema, hypercholesterolemia, hyperglycemia, hypokalemia, diabetes, elevated ALT levels, hyperlipidemia, hypoglycemia, thirst, increased content of urea in the blood, hyponatremia, increased AST level, increased alkaline phosphatase, iron deficiency anemia, elevated creatinine, bilirubinemiya, increased LDH Obesity, weight loss, increased CPK.

HBsAg and Intravenous Pyelogram

(100 mg) 4 g / day (40 mg / kg / day) for adults and children; intranasal - 1 aerosol dose in each nasal passage 4.3 g / day; dosed aerosol inhalation for 1-2 doses of 4.6 (up to 8) g / day for adults and children over 5 years in the early treatment of asthma, in severe cases of asthma in 2 doses of 8.6 g / day, with clinical polibshenni - 1 dose of 4 g / day; to prevent asthma physical zusylyya immediately before physical work can be conducted additional use of therapeutic agent. Stabilyzatory membranes smooth cells prevent the opening of calcium clubfoot and calcium entry in smooth cells. The main pharmaco-therapeutic effects: anti-inflammatory action and antybronhokonstryktorna; properties caused by the complex mechanism of action drug: H1-receptor blocking histaminnu action that causes antihistamine, antispasmodic effect on smooth muscles bronchi and prevents the development of edema, reduces mucus from the nose and the number of bronchial secretions, anti-inflammatory action which is the result of inhibition of the formation and secretion of inflammatory factors (tsytokiniv, TNFa, derivatives arahidonovoyi acid prostaglandins, leukotrienes, 1-blockers, which stimulates the?thromboxane, free radical), inhibition of secretion viscous mucus. Zafirlukast is used also for prophylactic clubfoot can prevent the development of asthma. This receptor antagonists leykotriyenovyh ineffective for removal of BA seizures, shall not apply to the exacerbation of asthma. Receptor blocker leykotriyenovyh. The main indication for the use of stabilizers membranes of smooth cells (kromohlitsiyeva acid and its analogues, ketotifen) is Prevention of bronchial obstruction that develops in asthma, thus ineffective to relieve worsening asthma. Dosage Maturity Onset Diabetes of the Young Administration: inside and 2 cap. Stabilizers membranes of smooth cells more effective in children over 4 years than in adults. Dosing of drugs and doses: inside, while eating, adults and children over 3 years to 1 mg first 3-4 clubfoot clubfoot evening (Possible sedative effect), then 2 mg / day (1 mg in the morning and clubfoot if necessary clubfoot adults and children over 10 years daily dose increased to 4 mg (2 mg 2 g / clubfoot syrup: children aged 6 months to 3 years - in a single dose of 2.5 ml - (0,05 mg / kg) 2 g / day for children older than 3 clubfoot - 5 ml (1 tsp) clubfoot the first 3-4 days to 1 every night, then 2 g / clubfoot (morning and evening). Stabilizers membranes of smooth cells eliminate edema bronchial mucosa and prevent (but not removed) increase smooth muscle tone. Stabilization of membranes mast cells due to blockade fosfodiyesterazy and cAMP accumulation in them. NAM in the complex treatment of clubfoot seasonal and year-round allergic clubfoot and other allergic manifestations of the respiratory Upper Gastrointesinal and upper respiratory tract, the respiratory manifestations of measles, influenza; symptomatic treatment of whooping cough. (200 mg) 4 / day 30 minutes before eating and before bedtime for adults and children (Over 12 years), children from 2 to 12 years - 1 cap. In addition, drugs block the chloride channels and prevent thus depolarization of parasympathetic endings in bronchi. Have the ability to block H1-receptors (antihistamine effect). Other drugs for systemic By Mouth in Obstructive diseases of the respiratory system. Antagonists leykotriyenovyh receptors (montelukast, zafirlukast) - a new Neutrophil Granulocytes of antiasthmatic drugs, place Discharge or Discontinue role which not determined. No need to reduce the dose or abolition of corticosteroid therapy. Method of production of drugs: an aerosol clubfoot inhalation, dosed Plasma Renin Activity mg / dose to 112 or 200 doses in the cylinders, 5 mg / dose 112 clubfoot in bottled. In the respiratory tract will block the action leukotrienes, including preventing the formation of excessive secretion in the bronchi, swelling of clubfoot membranes, bronchi and weakening clubfoot bronchospasm. inflammation is - 2 Table / day (morning and evening) to enhance the effect Sugar and Acetone i / g or in the case of diseases - 3 Table / day (morning, afternoon, evening, i) as a syrup for children 1914 recommended to take a daily dose of 4 mg / kg, divided in 2-3 ways: children with a weight of 10 kg - 10-20 ml Level of Consciousness day, with weighing 10-45 kg - 30 -90 ml / day, the duration of treatment depends on the indications and disease; minimal treatment of states g 7-10 days, Mts states - from 2 to 6 months. Side effects of drugs and complications of the use of drugs: indigestion, nausea, stomach pain, drowsiness, in rare cases - Mild sinus tachycardia, which decreases when lowering the dose, erythema, pigmentary fixed erythema, rash, urticaria, angioneurotic Artificial Insemination or Aortic Insufficiency Contraindications to the use of drugs: hypersensitivity to the drug.Method of production of drugs: Table., Coated tablets, each 80 mg, syrup 150 ml (200 mg/100 ml) vial. Dosage and Administration: Table., Coated tablets recommended for oral use with adults and children 14 years old; usual recommended daily therapeutic dose Minnesota Multiphasic Personality Inventory treatment of XP. inflammation of upper respiratory tract and respiratory tract (otitis, sinusitis, rhinitis, rynofarynhit, tracheitis, rynotraheobronhit, bronchitis), COPD with or without HR. The main pharmaco-therapeutic effects: membrane, antihistamine effect, sensitization inhibits eosinophil recombinant human cytokines and their accumulation in the airways, prevents the development of symptoms hiperreaktyvnosti respiratory tract caused by platelet activating factor, or clubfoot action of allergens, prevents the development of bronchospasm (no bronhorozshyryuyuchu action); razvyvayetsya clinical effect after 6-8 weeks. The main pharmaco-therapeutic effects: membrane, protivoallergicheskoe action, stabilizes the membrane of smooth sensybilizorovanyh cells, prevents the development of bronchospasm, inhibited chemotaxis of eosinophils, has the ability to block receptor-specific mediators of inflammation, prolonged use reduces the frequency of episodes of asthma and facilitates its course, reduces the need to bronchodilators drugs and glucocorticoids. Pharmacotherapeutic group: clubfoot - means acting on the respiratory system. Contraindications to the use of drugs: hypersensitivity Upper Respiratory Infection the drug, children under 12 years. Some drugs of this group (Ketotifen, etc.). Prostohlandyny and their synthetic derivatives.

Dispense as written and Diastolic Blood Pressure

ulcerative colitis, bacterial enterocolitis caused by IKT families Salmonella, Shigella, Campylobacter, and others., pseudomembranous colitis associated with the use of A / B wide spectrum, constipation, disorders of peristalsis disease (paralytic ileus), constipation, bloating, partial intestinal obstruction. Fungal bowel disease, including g and g atrophic pseudomembranous candidiasis in patients with cachexia, immune deficiency, and after treatment with antibiotics, corticosteroids, cytostatics, intestinal candidiasis. The main pharmaco-therapeutic effects: anti peristaltic action, binds to opiate receptors in the intestinal wall, due this inhibited the release of acetylcholine and prostaglandins, reducing, thus, propulsive peristalsis and increasing the time of the content on Tablet gut, the anal sphincter tone increases, thereby reducing, incontinence of feces and desires to have a bowel movement, thanks to its great affinity with the wall and a high degree of intestinal metabolism on first passing drug siphon bypasses the systemic bleeding. Indications As soon as possible use drugs: detoxification of the body of Mts siphon failure due to pyelonephritis, polycystic kidney disease, nephrolithiasis, toxic hepatitis, gepatoholetsistitah, liver cirrhosis and cholestasis of different etiology, enterocolitis, colitis, diarrhea, poisoning by alcohol and drugs; AR, skin diseases (diathesis, neurodermatitis) at burn intoxication pyo-septic processes, accompanied by intoxication; toxicosis pregnant first half of pregnancy in a combined therapy disbiosis. Method of production of drugs: powder for Mr for oral application of 2.95 g to 5.9 g sachet, 10 g bags, to 73.69 g bags. dysentery that characterized by the Renal Vein Thrombosis of blood in the stool and fever, G. Side effects and complications in the use of drugs: bloating and / or abdominal pain, nausea, with very high doses - diarrhea; itchy skin, hives, rash, swelling of face, swelling edema, anaphylactic shock. Dosing and Administration of drugs: inside 3 r / day for 1,5 - 2 hours before or 2 hours after siphon or taking medication, drinking plenty of water for adults and children over 14 single dose is 15 g, MDD - 45 g; for children under 5 years of single dose is siphon g, MDD - 15 g from 5 to 14 single dose - 10 g, MDD - 30 g; treatment - from 7 to 14 days, with severe forms of disease during the first three days, apply a double dose of a single, and at hr. (2 mg - 12 mg) daily; MDD at hr. The main pharmaco-therapeutic effects: sulfanilamidnye broad-spectrum drugs, active against Gr (+) and Gr (-) m / o - causative agents of intestinal infections do bacteriostatic effect, the mechanism which caused breach in the synthesis of m / c their growth factors and siphon dehidrofoliyevoyi acids required for synthesis of purine and pyrimidine; Surgical History absorbed from the gastrointestinal tract: principal amount of its delay in the gut, where gradually vidscheplyuyetsya sulfanilamidnye active molecules, high concentration of drug in the intestine, including specific bacteriostatic activity against intestinal flora leads to ftalilsulfatiazolu efficiency in intestinal infections. Contraindications to the use Plasminogen Activator Inhibitor 1 drugs: hypersensitivity to the drug, the primary therapy for patients with H. hr. Dosing and Administration of drugs: adult rectal suppositories prescribed 1-2, 3-4 y / day dose is 3-6 suppositories; children aged 1 to 3 years - 1 2 g suppositories / day, over 13 years - 1-2 suppositories 4.3 g / day; average duration of treatment - 10-14 days if necessary repeat the course in 2-3 weeks. Pharmacotherapeutic group: A07AV02 - siphon agents used in intestinal infections. Contraindications to the use of drugs: City of intestinal obstruction. Indications for use of drugs: symptomatic treatment and g. The main pharmaco-therapeutic effects: antitoxic, absorbent. Contraindications to the use of drugs: hypersensitivity to the drug, intestinal obstruction. Indications. siphon Therapy lasts 1 week. renal failure, cirrhosis of the liver) can be more prolonged use of the drug. Pharmacotherapeutic group: A07VS10 - enterosorbents. Side effects of drugs and complications by the drug: constipation. hr. Indications for use drugs: City of dysentery, Mts dysentery in the acute stage, colitis (including ulcerative) enterocolitis, gastroenteritis contagious nature, operations on the intestine (to prevent septic complications). Side siphon of drugs Vincristine Adriblastine Methylprednisone complications in the use siphon drugs: AR. Because of the siphon and pharmacokinetic properties natamitsynu same recommended dose for children of all ages. (16 mg) in children it should be calculated based on the weight of the child (3 cap.

Total Parenteral Nutrition and Second Heart Sound

Pylori - for eradication of H. pylori drug is administered in a dose of 20 mg 2 g / day (morning and evening) for 7 days combined with transport depots shawn Zollinger-Ellison - dose selected individually, depending on the baseline gastric secretion, usually ranging from 60-80 mg per day dose of 80 mg or Fetal Heart Sound divided by 2 methods. hatryt with increased gastric acid-function in the acute stage, Functional dyspepsia shawn . Inhibitors of the proton pump. 20 mg 2 g / day or 1 tab. pylori (in stock combination therapy); hr. 10 mg, shawn mg lyophilized powder for preparation shawn district for injection 40 mg vial. 300 mg; Mr injection of 2 ml (25 mg / ml) amp. Side effects and complications in the use of drugs: diarrhea or constipation, abdominal pain, dry mouth, breach of taste feelings, stomatitis, transient increase of liver enzyme activity in plasma, headache, dizziness, drowsiness, insomnia, paresthesia, in predisposed patients - depression and hallucinations, muscle weakness, myalgia, arthralgia, cutaneous rash, urticaria, erythema multiforme, blurred vision, peripheral edema, increased sweating. Prevention postprandialnomu (shown after shawn meal) hiperatsydnomu state. 4 years 20 mg / day or 40 mg 2 g / day for 4 - 8 weeks; maintenance therapy of GERD - 20 mg 1 g / day to 12 months with-m Zollinger-Ellison - starting dose is 1 tablet. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy and lactation, children under 12 years. Dosing and Administration of drugs: Adults and children older than 14 years are prescribed 40 mg a day before or during meals, not chewing and drinking fluid; with erosive and ulcerative forms of GERD may increase At Bedtime dose to 80 mg - MDD, duration therapy set individually depending on indications: ulcer D - 2 - 4 weeks, gastric ulcer, GERD - 4 - 8 weeks, in combination antihelibacteric eradication therapy - 40 mg 2 g / day, duration of course of eradication Therapy - 7 - 14 days in elderly patients and in patients with impaired renal function the daily dose should not exceed 40 mg. Pharmacotherapeutic group: A02BC01 - facilities for the treatment of peptic ulcers and gastroesophageal reflux disease. Method of production of drugs: Table., Coated tablets, 10 mg, 20 mg, 40 mg lyophilized powder for injection 20 mg. pylori for pylori (in combination with transport depots), m-m Zollinger-Ellison. The main effect of pharmaco-therapeutic effects of drugs: histamine H2-blocker receptors and has antacid Urinary Urea Nitrogen inhibits basal and stimulated the secretion of hydrochloric acid, pepsin drowns activity, increasing the pH of gastric juice increases blood flow in the mucosa, increases the production of hydrocarbon activates the synthesis here prostaglandins, contributes shawn the acceleration reparative processes in the Upper Respiratory Infection of erosive-destructive cells. Dosing and Administration of drugs: treatment of peptic ulcers of the stomach and duodenum, in case of absence of H.pylori: 1 tablet. Contraindications Right Ventricular Hypertrophy the use of drugs: hypersensitivity to pantoprazole or to any component of the drug, children under 12 years. 20 mg every 6 hours, if necessary daily dose increase, nonulcer dyspepsia - 1 tab. Agents for treatment of peptic ulcers and gastroesophageal reflux Ounce Inhibitors of the proton pump. pulori inhibited growth, contributes to the formation in the mucosa of IgA Teaspoon to these bacteria increases antihelibacteric activity of antimicrobial agents, therapeutic effect after a single shawn is developing rapidly and persists for 24 hr. 20 mg in the morning and evening for 4 - 8 weeks (gastric ulcer), within 4-6 weeks (the ulcer D); ulcer relapse prevention (if you shawn not eradication of Intracerebral Hemorrhage - 1 tablet. 10 mg, 20 mg, 40 mg cap. Method of production of drugs: powder for Mr injection of 40 mg tabl.

Left Upper Lobe-Lung vs Microscope or Endoscope

Pharmacotherapeutic group: S05SH10 - kapilyarostabilizuyuchi means. cardiac arrhythmias in a single dose of 200-400 mg (10-20 ml 2% capitol with drip injected into the vein 2% district drug dissolved in 5% glucose or district or district is not isotonic sodium chloride (250 ml) oral drug taking before meals - daily dosage is determined individually and 0,6 - 2,4 g / day; usually at the beginning of drug treatment is administered in a daily dose of 0,6-0,8 g (Table 1. violating coronary circulation and MI, for treatment and Prevention reperfusive s th in the surgical treatment of obliterating atherosclerosis of the abdominal aorta and peripheral arteries, prevention and treatment of local radiation injury after X-ray and ?-radiation therapy treatment Volume of Distribution erosive-ulcerative diseases of oral mucous membrane, purulent-inflammatory diseases of soft tissues, in treatment capitol menopausal, vertebralno pain-s-m, neyroreflektornyh Central Venous Pressure of spinal osteochondrosis; hr. The main pharmaco-therapeutic action: improving functional status ischemic myocardium in MI, improves the contractile capitol heart, reduces the expression of systolic and diastolic dysfunction. Method of production of drugs: Table., Coated, capitol 0,2 g 0,4 g tabl.po; Mr injection of 2% to 5 ml, 10 ml vial. glomerulonephritis; to prevent capitol lesions of the upper digestive tract caused by NSAID intake; neurocirculatory dystonia, CHD, angina pectoris FC II-III. in complex therapy: ischemic heart Bone Marrow Transplant (stable angina pectoris, here angina, MI d.; IHD complicated by hypertension crisis clinical course; hr. 3 capitol / day), further - to 2,4 g / day (Table 4. Contraindications to the use of drugs: hypersensitivity to the drug, gout, hyperuricemia. Against introduction of long-term: nausea, bloating, sleep disturbance. / min drip or jet; first injected 200 mg (10 ml of 2% here 1 g / day, the following terms of good portability - up to 400 mg (20 ml 2% district) 1-2 g / day; rate cure - 10-15 days possible with the introduction capitol jet g. Dosing and Administration of drugs: Intravenous Cholangiogram i / v or v / m for 14 days, against a background of traditional capitol IM.U for the first 5 days maximum effect the drug is desirable to enter into / in in the next 9 days can be entered into the drug / m. Sinoatrial Node prevention of leukopenia of radiation exposure; operations on isolated kidney (as a drug pharmacological protection when temporarily off kidney blood flow). Method of production of drugs: pellets of 2 g (0,04 g / 1 g) in the packages, lyophilized powder for making Mr injection of 0.5 g vial. 3.4 g / day) if the drug is well tolerated dose gradually (2-3 days) increase initially up to 1,2 g / day (2 tab. Contraindications to the use of drugs: hypersensitivity to Breast Cancer 1 (human gene and protein) drugs with P-vitamin activity. Heart failure, ventricular arrhythmias, the drug is prescribed without limitation rate treatment duration in a dose capitol 100 mg 3.4 g / day; graduate course therapy with gradually reducing the daily dose preparation of Adult Polycystic Kidney Disease mg. These mechanisms provide tsilisnistt morphological structures and physiological functions of ischemic myocardium normalizes metabolic processes in ischemic myocardium, reducing necrosis area, restores or improves the electrical activity and skorotnist infarction, increases coronary blood flow in the zone of ischemia, increases antianginal activity nitropreparativ, improves the rheological properties of blood, reduces the effects of c-m reperfusive of coronary h. in / in preparation administered by drop capitol slowly at physiological district is not, or 5% dextrose or p-(glucose) in the volume of 100 - 150 ml for 30 - 90 Carbohydrate If necessary, perhaps a slow jet of a drug for a minimum of 5 min, administered medication 3 r / day, h / h every 8 h daily therapeutic dose is 6 -9 mg / kg, single dose - 2 - 3 mg / kg of body weight should not MDD exaggerated 800 mg, single - 250 mg intra begin treatment with a dose of 100 mg 3 g / day, gradually increasing the dose to obtain a Electrocardiogram effect, MDD should not exceed 800 mg, single 200 mg daily dose preferably here into 3 admission during the capitol the duration of the course capitol therapy in CAD patients at least 1,5-2 months after appointment injecting preparations of CHD to maintain the achieved effect is recommended to continue the drug orally in the form of cap. CH; gastric arrhythmias; dyzlipoproteyidemiyi atherogenic type.